Spotting ILDs may be challenging. Symptoms such as a dry cough, shortness of breath, and unexplained weight loss may go ...

Technological Advancements in Diagnosis and Treatment Transforming Interstitial Lung Disease CareThe Global Interstitial Lung ...

The DJS Law Group announces that it is investigating claims on behalf of investors of aTyr Pharma, Inc. ("aTyr" or "the Company") for violations of the securities laws. INVESTIGATION DETAILS: The ...

The Gala will be emceed by Jeryl Prescott Gallien, celebrity spokesperson for FSR’s Ignore No More Campaign and recipient of ...

Clinical benefit for efzofitimod across multiple disease-related health outcomes reported.Improvement in Fatigue Assessment Scale Total Score at ...

The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann ...

Tyr Pharma (ATYR) presented additional findings from the Phase 3 EFZO-FIT study of efzofitimod in 268 patients with pulmonary sarcoidosis, a ...

CHEST receives a Mayoral Proclamation from the City of Chicago that the first day of the CHEST 2025 Annual Meeting, October 19, 2025, will be declared "Love Your Lungs Day" to recognize the dedication ...

The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), today announced that the Ann Theodore Foundation ...

Detailed price information for Atyr Pharma Inc (ATYR-Q) from The Globe and Mail including charting and trades.

The study was conducted in 268 patients with pulmonary sarcoidosis, a major form of interstitial lung disease. Following this news, aTyr hit a new 52-week low following several analyst downgrades.

He went to a nearby emergency clinic, where doctors told him that he was probably constipated. They gave him some laxatives ...